Recapitulation of Transcriptomic Characteristics of Primary Breast Tumours in Patient-Derived 3D Cultures in Vitro

Astashkina, A., Mann, B., Grainger, D. W. (2012). A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol. Ther., 134, 82–106.10.1016/j.pharmthera.2012.01.00122252140Search in Google Scholar

Azadi, M., Jamali, T., Kianmehr, Z., Kavoosi, G., Ardestani, S. K. (2020). In-vitro (2D and 3D cultures) and in-vivo cytotoxic properties of Zataria multiflora essential oil (ZEO) emulsion in breast and cervical cancer cells along with the investigation of immunomodulatory potential. J. Ethnopharmacol., 257, 112865.10.1016/j.jep.2020.11286532298750Search in Google Scholar

Baker, B. M., Chen, C. S. (2012). Deconstructing the third dimension — how 3D culture microenvironments alter cellular cues. J. Cell. Sci., 125 (Pt 13), 3015–3024.10.1242/jcs.079509343484622797912Search in Google Scholar

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., Jemal, A. (2018). Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.,68 (6), 394–424.10.3322/caac.2149230207593Search in Google Scholar

Bleijs, M., van de Wetering, M., Clevers, H., Drost, J. (2019). Xenograft and organoid model systems in cancer research. EMBO J., 38 (15), e101654.10.15252/embj.2019101654667001531282586Search in Google Scholar

Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S. et al. (2015). Organoid models of human and mouse ductal pancreatic cancer. Cell, 160 (1–2), 324–338.10.1016/j.cell.2014.12.021433457225557080Search in Google Scholar

Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio I. T., Zackrisson, S., Senkus, E. (2019). Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 30 (8), 1194–1220.10.1093/annonc/mdz17331161190Search in Google Scholar

DeRose, Y. S., Gligorich, K. M., Wang, G., Georgelas, A., Bowman, P., Courdy, S. J., Welm, A. L., Welm, B. E. (2013). Patient-derived models of human breast cancer: Protocols for in vitro and in vivo applications in tumor biology and translational medicine. Curr. Protoc. Pharmacol, Chapt. 14, Unit14.23.10.1002/0471141755.ph1423s60363051123456611Search in Google Scholar

Goldhammer, N., Kim, J., Timmermans-Wielenga, V., Petersen, O. W. (2019). Characterization of organoid cultured human breast cancer. Breast Cancer Res., 21, 141.10.1186/s13058-019-1233-x690726531829259Search in Google Scholar

Muguruma, M., Teraoka, S., Miyahara, K., Ueda, A., Asaoka, M., Okazaki, M., Kawate, T., Kuroda, M., Miyagi, Y., Ishikawa, T. (2020) Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines. Biochem. Biophys. Res. Commun., 533 (3), 268–274.10.1016/j.bbrc.2020.08.07532958246Search in Google Scholar

Pirsko, V., Čakstiņa, I., Nitiša, D., Samoviča, M., Daneberga, Z., Miklaševičs, E. (2019). Alterations of the stem-like properties in the breast cancer cell line MDA-MB-231 induced by single pulsed doxorubicin treatment. Proc. Latvian Acad. Sci., Section B, 73 (2), 89–99.10.2478/prolas-2019-0015Search in Google Scholar

Ramakrishnan, A.-B., Cadigan, K. M. (2017). Wnt target genes and where to find them. F1000Research, 6 (F1000 Faculty Rev), 746.10.12688/f1000research.11034.1546421928649368Search in Google Scholar

Sachs, N., Clevers, H. (2014). Organoid cultures for the analysis of cancer phenotypes. Curr. Opin. in Genet. Dev., 24, 68–73.10.1016/j.gde.2013.11.01224657539Search in Google Scholar

Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H. et al. (2018). A living biobank of breast cancer organoids captures disease heterogeneity. Cell, 172, 373–386.10.1016/j.cell.2017.11.01029224780Search in Google Scholar

van Schie, E. H., van Amergongen, R. (2020) Aberrant WNT/ CTNNB1 signaling as a therapeutic target in human breast cancer: Weighing the evidence. Front. Cell Dev. Biol., 31, 25.Search in Google Scholar